MedTrace Logo

Intra-arterial Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke

NCT02178657 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2024-02-07

No results posted yet for this study

Summary

This trial aims to test that intra-arterial injection of autologous bone marrow mononuclear cells in acute ischemic stroke patients is safe and improves neurological outcomes.

Conditions

Interventions

DRUG

Autologous bone marrow mononuclear cell intra-arterial injection

Sponsors & Collaborators

  • Andalusian Initiative for Advanced Therapies

    lead OTHER_GOV

Principal Investigators

  • Francisco Moniche, MD, PhD · Hospitales Universitarios Virgen del Rocio

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2021-10-27
Completion
2023-04-12

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02178657 on ClinicalTrials.gov